Table 2.
Covariates | Category | Death (%) | Censored (%) | Total (%) |
---|---|---|---|---|
Any clinical complication | No complication | 35(20.35) | 137(79.65) | 172 |
Pneumonia | 7(87.5) | 1(12.5) | 8 | |
Pneumothorax | 6(85.71) | 1(14.29) | 7 | |
Hemoptysis | 7(63.64) | 4(36.36) | 11 | |
Cor pulmonal | 4(100) | 0(0) | 4 | |
Other | 2(40) | 3(60) | 5 | |
HIV Co-infection | Positive | 21(61.76) | 13(38.24) | 34 |
Negative | 40(23.12) | 133(76.88) | 173 | |
Acid-fast bacilli Smear (AFB) | positive | 43(28.28) | 109(71.71) | 152 |
Negative | 12(30) | 28(70) | 40 | |
Antibiotic Susceptibility | INH | 6(72.86) | 8(57.14) | 14 |
RMP | 24(30.38) | 55(69.62) | 79 | |
MDR | 26(30.95) | 58(69.05) | 84 | |
INH+RMP | 5(16.67) | 25(83.33) | 30 | |
Presence of any chronic disease | No chronic disease | 42(24.14) | 132(75.86) | 174 |
Diabetes Mellitus | 8(50) | 8(50) | 16 | |
Myocardial infarction | 4(100) | 0(0) | 4 | |
Asthma | 4(66.66) | 2(33.33) | 6 | |
other | 1(33.33) | 2(66.67) | 3 | |
Radiological findings | unilateral cavity | 9(26.47) | 25(73.53) | 34 |
unilateral infiltration | 3(33.33) | 6(66.67) | 9 | |
Bilateral cavity | 4(18.18) | 18(81.82) | 22 | |
Bilateral inflation | 7(38.89) | 11(61.12) | 18 | |
Non cavity | 14(27.45) | 37(72.55) | 51 | |
Effusion | 12(37.5) | 20(62.5) | 32 | |
Smear positivity | Positive | 46(31.94) | 98(68.06) | 144 |
Negative | 14(26.42) | 39(73.58) | 53 | |
Clinical Presentation | Pulmonary | 51(30) | 119(70) | 170 |
Extra pulmonary | 8(28.57) | 20(71.43) | 28 |
INH: isoniazid; RMP: rifampicin; MDR: multidrug-resistant.